Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer

Method of using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRα as a therapeutic target for the treatment of breast cancer

US Patent 7541141 · Granted Jun 2, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for high-depth sequencing of methylated nucleic acid2025
Methods and systems for high-depth sequencing of methylated nucleic acid2025
Machine learning implementation for multi-analyte assay development and testing2023
Machine learning implementation for multi-analyte assay development and testing2023
Method of using estrogen-related receptor gamma (ERRγ) status to determine progn2008
Method of using estrogen-related receptor gamma (ERRγ) status to determine progn2008
Pre-mRNA processing enhancer and method for intron-independent gene expression1999
Identification of differentially expressed genes1997
Pre-mRNA processing enhancer and method for intron-independent gene expression1997
Portable urinal1985